Clinical Trials Directory

Trials / Completed

CompletedNCT00570843

Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

Phase 4 Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Bp Consulting, Inc · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.

Conditions

Interventions

TypeNameDescription
DRUGNew PEG based artificial tear1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)
DRUGOptive1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)

Timeline

Start date
2008-03-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2007-12-11
Last updated
2010-02-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00570843. Inclusion in this directory is not an endorsement.